GREENHAVEN ASSOCIATES INC, a registered investment adviser, initiated a new position in Baxter International Inc. (NYSE:BAX) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 10,693,223 shares of the Healthcare company, valued at approximately $204,347,492 as of the filing date.
Baxter International Inc.'s stock currently trades at $20.40 with a market capitalization of $9,714,532,451.
